TuHURA BIOSCIENCES, INC./NV Preferred Stock, Shares Authorized
TuHURA BIOSCIENCES, INC./NV (HURA) had Preferred Stock, Shares Authorized of 5.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-14
- 2026-06-30: Preferred Stock, Shares Authorized 5.00M shares.
- 2026-03-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2025-12-31: Preferred Stock, Shares Authorized 5.00M shares.
- 2025-09-30: Preferred Stock, Shares Authorized 5.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2026-06-30 | 5.00M shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 5.00M shares 10-Q · filed 2026-05-15 |
| 2025-12-31 | 5.00M shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 5.00M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 5.00M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 5.00M shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 5.00M shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 5.00M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 5.00M shares 10-Q · filed 2024-11-14 |
| 2024-03-31 | 5.00M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 5.00M shares 10-Q · filed 2024-02-14 |
| 2023-09-30 | 5.00M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 5.00M shares 10-K · filed 2024-10-07 |
| 2023-03-31 | 5.00M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 5.00M shares 10-Q · filed 2023-02-14 |
| 2022-09-30 | 5.00M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 5.00M shares 10-K · filed 2023-09-18 |
| 2022-03-31 | 5.00M shares 10-Q · filed 2022-05-13 |
| 2021-12-31 | 5.00M shares 10-Q · filed 2022-02-11 |
| 2021-09-30 | 5.00M shares 10-Q · filed 2021-11-15 |
| 2021-06-30 | 5.00M shares 10-K · filed 2022-09-27 |
| 2021-03-31 | 5.00M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 5.00M shares 10-Q · filed 2021-02-12 |
| 2020-09-30 | 5.00M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 5.00M shares 10-K · filed 2021-09-28 |
| 2020-03-31 | 5.00M shares 10-Q · filed 2020-05-13 |
| 2019-12-31 | 5.00M shares 10-Q · filed 2020-02-13 |
| 2019-09-30 | 5.00M shares 10-Q · filed 2019-11-13 |
| 2019-06-30 | 5.00M shares 10-K · filed 2020-09-18 |
| 2019-03-31 | 5.00M shares 10-Q · filed 2019-05-14 |
| 2018-12-31 | 5.00M shares 10-Q · filed 2019-02-11 |
| 2018-09-30 | 5.00M shares 10-Q · filed 2018-11-13 |
| 2018-06-30 | 5.00M shares 10-K · filed 2019-09-09 |
| 2018-03-31 | 5.00M shares 10-Q · filed 2018-05-15 |
| 2017-12-31 | 5.00M shares 10-Q · filed 2018-02-14 |
| 2017-09-30 | 5.00M shares 10-Q · filed 2017-11-09 |
| 2017-06-30 | 5.00M shares 8-K · filed 2019-06-03 |
| 2017-03-31 | 5.00M shares 10-Q · filed 2017-05-12 |
| 2016-12-31 | 5.00M shares 10-Q · filed 2017-02-10 |
| 2016-09-30 | 5.00M shares 10-Q · filed 2016-11-10 |
| 2016-06-30 | 5.00M shares 10-K · filed 2017-09-27 |
| 2016-03-31 | 5.00M shares 10-Q · filed 2016-05-12 |
| 2015-12-31 | 5.00M shares 10-Q · filed 2016-02-12 |
| 2015-09-30 | 5.00M shares 10-Q · filed 2015-11-16 |
| 2015-06-30 | 5.00M shares 10-K · filed 2016-09-13 |
| 2015-03-31 | 5.00M shares 10-Q · filed 2015-05-15 |
| 2014-12-31 | 5.00M shares 10-Q · filed 2015-02-12 |
| 2014-09-30 | 5.00M shares 10-Q · filed 2014-11-07 |
| 2014-06-30 | 5.00M shares 10-K · filed 2015-11-16 |
| 2014-03-31 | 5.00M shares 10-Q · filed 2014-05-15 |
| 2013-12-31 | 5.00M shares 10-K · filed 2014-08-28 |
| 2013-09-30 | 5.00M shares 10-Q · filed 2013-11-08 |
| 2013-06-30 | 5.00M shares 10-Q · filed 2013-08-12 |
| 2013-03-31 | 5.00M shares 10-Q · filed 2013-05-15 |
| 2012-12-31 | 5.00M shares 10-K · filed 2014-08-28 |
| 2012-09-30 | 5.00M shares 10-Q/A · filed 2012-12-20 |
| 2012-06-30 | 5.00M shares 10-Q · filed 2013-01-18 |
| 2011-06-30 | 5.00M shares 10-K/A · filed 2012-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |